About Phastar
Phastar is a company based in London (United Kingdom) founded in 2007 by Kevin Kane. Phastar has completed 1 acquisition, including S-Cubed. Phastar offers products and services including Clinical Data Solutions, Biostatistical Programming, and Data Management Services. Phastar operates in a competitive market with competitors including SSI Strategy, Fusion Antibodies, Health Decisions, Antios Therapeutics and Everest Clinical Research, among others.
- Headquarter London, United Kingdom
- Founders Kevin Kane
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Phastar
Phastar offers a comprehensive portfolio of products and services, including Clinical Data Solutions, Biostatistical Programming, and Data Management Services.
Provides tools for biostatistical analysis and data visualization in trials
Offers programming for clinical trial design and result interpretation
Supports data collection and quality assurance for drug development
People of Phastar
Unlock access to complete
Funding Insights of Phastar
Investors in Phastar
Phastar has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Charterhouse Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are managed by Charterhouse Capital Partners.
|
Locked | Locked | Locked |
Investor details for Phastar
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Phastar
Phastar has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include S-Cubed.
Investment portfolio details for Phastar
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Specialized consulting in clinical biometrics and regulatory affairs is provided.
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Phastar
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Phastar
Detailed financials for Phastar
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Phastar Comparisons
Peer comparison for Phastar
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Phastar
Phastar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SSI Strategy, Fusion Antibodies, Health Decisions, Antios Therapeutics and Everest Clinical Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmacovigilance and medical affairs services are offered for drug development.
|
|
| Locked | Locked | Locked |
Company offering a range of services in antibody production, development, characterization and optimization right from discovery to commercialization
|
|
| Locked | Locked | Locked |
CRO focused on clinical trial services for data management, monitoring and biostatistics
|
|
| Locked | Locked | Locked |
Innovative therapies for treating and curing viral diseases are developed.
|
|
| Locked | Locked | Locked |
Full-service clinical research services are provided to life science industries.
|
|
| Locked | Locked | Locked |
Regulatory and pharmacovigilance support is provided for product lifecycles.
|
Detailed competitors of Phastar
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Phastar
Complete news archive for Phastar
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Phastar
Phastar was founded in 2007 and raised its 1st funding round 14 years after it was founded.
Phastar is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Kevin Kane is the current CEO of Phastar. They have also founded this company.
Phastar was founded in 2007 and is headquartered in London, United Kingdom. As a specialist contract research organization, statistical services are provided to support clinical trials, including input into study design, protocol development, adaptive designs, sample size calculations, analysis plans, modeling, simulation, regulatory advice, observational studies, data visualization, and statistical training. Operations focus on optimizing trial success and interpreting results for pharmaceutical clients.
Phastar's top competitors include SSI Strategy, Fusion Antibodies and ProductLife Group.
Phastar offers Clinical Data Solutions, Biostatistical Programming, and Data Management Services.
Phastar has made 1 acquisition, including S-Cubed.
Phastar has 1 investor. Key investors include Charterhouse Capital Partners.